APA (7th ed.) Citation

Dini, F. L., Buralli, S., Bajraktari, G., Elezi, S., Duranti, E., Metelli, M. R., . . . Taddei, S. (2010). Plasma matrix metalloproteinase-9 better predicts outcome than N-terminal protype-B natriuretic peptide in patients with systolic heart failure and a high prevalence of coronary artery disease. Biomedicine & Pharmacotherapy, 64(5), 339. https://doi.org/10.1016/j.biopha.2009.09.008

Chicago Style (17th ed.) Citation

Dini, Frank Lloyd, Simona Buralli, Gani Bajraktari, Shpend Elezi, Emiliano Duranti, Maria Rita Metelli, Angelo Carpi, and Stefano Taddei. "Plasma Matrix Metalloproteinase-9 Better Predicts Outcome than N-terminal Protype-B Natriuretic Peptide in Patients with Systolic Heart Failure and a High Prevalence of Coronary Artery Disease." Biomedicine & Pharmacotherapy 64, no. 5 (2010): 339. https://doi.org/10.1016/j.biopha.2009.09.008.

MLA (9th ed.) Citation

Dini, Frank Lloyd, et al. "Plasma Matrix Metalloproteinase-9 Better Predicts Outcome than N-terminal Protype-B Natriuretic Peptide in Patients with Systolic Heart Failure and a High Prevalence of Coronary Artery Disease." Biomedicine & Pharmacotherapy, vol. 64, no. 5, 2010, p. 339, https://doi.org/10.1016/j.biopha.2009.09.008.